Probiotec Limited appointed Graham Morton as a director of the company. More recently, Mr. Morton was CEO of a UK based Investment group with a focus on global investments in pre-IPO and small to mid capitalisation companies in the technology, biotechnology and healthcare sectors. Mr. Morton will join the board as an addition to the existing directors until the Company's Annual General Meeting on 29 November 2016, when he will be eligible for re-election.